SOMERSET, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare information technology and generative AI solutions for medical practices and health systems nationwide, announced today that it will formally notify The Nasdaq Stock Market LLC of its intent to voluntarily delist its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock (Nasdaq: CCLDP) (“Series A Preferred Stock”) from the Nasdaq Global Market. The Company expects ...

Core Viewpoint - CareCloud, Inc. has announced the mandatory conversion of its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock into Common Stock, which is expected to eliminate approximately $7 million in annual dividend obligations and improve the company's capital structure [1][2]. Group 1: Conversion Details - The conversion will be effective at 4:01 p.m. Eastern Time on March 6, 2025, with each share of Preferred Stock converting into 7.3358 shares of Common Stock, including all accumulated and unpaid dividends [2][3]. - Shareholders holding at least 100,000 shares of Preferred Stock will retain the right to object to the conversion if their shares are held by the company's transfer agent [3]. Group 2: Financial Implications - The conversion is anticipated to free up capital for reinvestment in growth initiatives, enhancing the company's ability to create shareholder value [2]. - The elimination of dividend obligations is expected to provide greater flexibility in managing the company's financial resources [2]. Group 3: Company Overview - CareCloud specializes in healthcare information technology and generative AI solutions, serving over 40,000 providers to improve patient care while reducing administrative burdens and operating costs [5].

Core Viewpoint - CareCloud, Inc. is resuming its acquisition strategy to enhance its position in the healthcare technology and revenue cycle management sectors, starting with the acquisition of Mesa, LLC, which was finalized on February 28, 2025 [2][3]. Group 1: Acquisition Strategy - The acquisition of Mesa, LLC marks CareCloud's first step in a renewed aggressive expansion strategy, aiming to reinforce its leadership in the healthcare billing industry [2][3]. - CareCloud has a history of successful acquisitions, having completed over 20 deals between 2012 and 2022, achieving a compound annual growth rate (CAGR) of over 30% during that period [3]. - The company is shifting back into high gear for acquisitions after a pause since Q2 2021, with MesaBilling being the starting point for this new phase [3]. Group 2: Market Context - The renewed focus on acquisitions aligns with a growing demand from medical practices for streamlined, technology-enabled financial management solutions [4]. - CareCloud plans to leverage its proprietary technology, including AI-powered revenue cycle management and automation tools, to expand its platform and serve a broader network of healthcare providers [4]. Group 3: Company Overview - CareCloud provides a suite of AI and technology-enabled solutions aimed at improving financial and operational performance, streamlining clinical workflows, and enhancing patient experiences [5]. - The company serves over 40,000 providers, helping them reduce administrative burdens and operating costs while improving patient care [5].

SOMERSET, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the fourth quarter and full year ended December 31, 2024 before the market opens on Thursday, March 13, 2025. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation ...

Core Points - CareCloud, Inc. has announced the transfer of funds for January 2025 dividend payments on its Series A and Series B Cumulative Redeemable Perpetual Preferred Stock [1][2] - Holders of Series A Preferred Stock will receive a dividend of 22.917 cents per share, while holders of Series B Preferred Stock will receive 18.229 cents per share, with a record date of January 31, 2025 [2][9] - The dividend payments are expected to be reflected in shareholders' brokerage accounts between February 18 and February 20, 2025 [2][9] Financial Management - The Interim Chief Financial Officer of CareCloud, Norman Roth, emphasized the company's commitment to responsible fiscal management and financial stability [3] - Dividends for both Series A and Series B Preferred Stock are cumulative and payable monthly, in arrears, on the 15th of each month or the next business day if the 15th is a bank holiday or weekend [3] Shareholder Communication - Shareholders who do not see their dividend payment by the end of the following week are encouraged to contact their broker for assistance [4] - For further inquiries, the CareCloud Investor Relations team can be reached via email [4] Company Overview - CareCloud provides a suite of AI and technology-enabled solutions aimed at improving financial and operational performance in healthcare [5] - The company serves over 40,000 providers, helping them enhance patient care while reducing administrative burdens and operating costs [5]

Streamlining the Referral Process to Enhance Efficiency and Patient Experience SOMERSET, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and AI-driven solutions, is proud to announce the launch of its new advanced referral module. This innovative solution is designed to simplify the referral process for medical providers and enhance the patient experience through advanced automation and location-based guidance. By optimizing referrals t ...

Core Insights - CareCloud, Inc. has launched an advanced referral module aimed at streamlining the referral process for medical providers and enhancing patient experience through automation and location-based guidance [1][3] - The new module allows healthcare providers to save up to 70% of the time typically spent on managing referrals, enabling a more patient-focused approach [1][3] User Feedback - 92% of surveyed users rated CareCloud's advanced referral module as "exceptional," highlighting its ease of use and efficiency in enhancing patient satisfaction [2][3] - Users have noted that the module transforms the referral process by allowing real-time completion during patient visits, which improves both efficiency and patient experience [2][3] Key Features - Real-Time Referral Completion: Providers can complete referral forms while the patient is still in the office, ensuring accuracy and efficiency [6] - Specialist Recommendations with Location Guidance: Integrated maps help doctors recommend nearby specialists, enhancing convenience for patients [6] - Secure Patient Notifications: Patients receive text messages with a curated list of specialists and secure links to detailed information [6] - Seamless Appointment Booking: Patients can book appointments directly through secure links, with automatic forwarding of referral forms to specialists [6] - Patient Access to Referral Documentation: Patients can securely download or access their referral forms through their Personal Health Record [6] Company Overview - CareCloud focuses on disciplined innovation in healthcare, offering AI and technology-enabled solutions to improve financial and operational performance, streamline workflows, and enhance patient experience [4] - The company serves over 40,000 providers, helping them improve patient care while reducing administrative burdens and operating costs [4]

SOC 2 Type 2 Attestation Positions CareCloud Among a Select Group of less than 10% of all EHR Vendors SOMERSET, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leader in healthcare technology and AI-driven solutions, today announced that it has successfully completed a SOC 2 Type 2 examination for the second consecutive year, receiving a clean report with no exceptions. The examination scope of the Healthcare IT systems, performed by an independent CPA ...

Somerset, NJ, Jan. 28, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP)), a leading provider of healthcare technology and generative AI solutions for medical practices and health systems nationwide, is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025 at the Borgata Hotel Spa & Casino in Atlantic City, NJ. CareCloud's management team will d ...

SOMERSET, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leading provider of healthcare technology and generative AI solutions for medical practices and health systems nationwide, today held its special meeting (“Special Meeting”) of CareCloud’s common stock shareholders. At the Special Meeting, a record-breaking 10.8 million shareholders, representing 85% of the votes cast, approved an amendment to the Company’s Certificate of Incorporation to increa ...